Pharma And Biotech CRM Software Industry Insights: Market Forecast to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Is The Pharma And Biotech CRM Software Market Size Likely To Evolve From 2025 Through 2034?

The pharma and biotech crm software market size has experienced rapid growth in recent years. It is projected to expand from $7.39 billion in 2024 to $8.7 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 17.6%. The historical growth can be attributed to factors such as a transition towards a customer-centric approach, the expansion of sales and marketing channels, a heightened demand for data analytics, an increased need for efficiency and productivity, and a focus on delivering an enhanced customer experience.

The market size for pharmaceutical and biotech CRM software is anticipated to undergo significant expansion in the coming years. It is predicted to reach $16.06 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 16.6%. This projected growth can be attributed to a focus on AI-powered customer insights, the rise of virtual engagement solutions, integration with the wider healthcare ecosystem, stringent compliance and data security measures, and the expansion of mobile and remote access. Prominent trends expected during this forecast period include AI-powered customer insights, predictive analytics tailored for healthcare providers, a patient-centered approach, various virtual engagement solutions, and a strong emphasis on digital marketing.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15442&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Pharma And Biotech CRM Software Industry?

The increasing requirement for personalized medicine is anticipated to drive the expansion of the pharma and biotech CRM software market. This medical approach tailors healthcare decisions and treatments for each patient, considering their unique genetic profile, environmental influences, and lifestyle choices. This rising demand for personalized medications stems from elevated cancer rates and a greater prevalence of chronic illnesses within the population. The necessity for tailored medicine mandates the use of pharma and biotech CRM software for effective management of patient information, monitoring treatment results, and streamlining the provision of customized healthcare. For example, the Personalized Medicine Coalition, a US-based professional body, reported that 12 new customized medications received approval in 2022, constituting approximately 34% of all newly approved therapies, marking a substantial rise compared to previous years. Consequently, the escalating need for personalized medicine is fueling the expansion of the pharma and biotech CRM software market.

What Are The Major Segments Identified In The Pharma And Biotech CRM Software Market?

The pharma and biotech crm softwaremarket covered in this report is segmented –

1) By Technology: Artificial Intelligence Customer Relationship Management (CRM); Conventional Customer Relationship Management (CRM)

2) By Deployment: On-Premises; Cloud Based

3) By Enterprise Size: Large Enterprise; Small And Medium Enterprise (SMEs)

4) By Industry: Pharmaceuticals; Biotech

Subsegments:

1) By Artificial Intelligence Customer Relationship Management (CRM): AI-Powered Sales Automation; AI-Driven Customer Insights And Analytics; Predictive Analytics For Lead Scoring; Chatbots And Virtual Assistants; Natural Language Processing (NLP) For Customer Interaction; Personalized Marketing And Campaign Management; Sentiment Analysis And Customer Feedback Analysis; Machine Learning For Sales Forecasting

2) By Conventional Customer Relationship Management (CRM): Contact And Lead Management; Sales Pipeline And Opportunity Management; Marketing Automation And Campaign Management; Customer Service And Support Modules; Email Marketing And Communication Tools; Customer Segmentation And Targeting; Activity Tracking And Reporting; Integration With ERP And Other Business Systems

Which Ongoing Trends Are Expected To Shape The Pharma And Biotech CRM Software Market Outlook?

Key companies operating in the pharma and biotech CRM software market are increasingly integrating artificial intelligence (AI) and machine learning capabilities into their platforms, such as AI-powered personalized engagement platforms, to satisfy the growing demand for advanced customer relationship management tools tailored specifically for the pharmaceutical and biotechnology industries. AI-powered personalized engagement enables businesses to deliver precise and relevant messages to healthcare professionals (HCPs), patients, and other stakeholders. For instance, in October 2023, Salesforce, Inc., a US-based provider of cloud-based software solutions, launched its new life sciences cloud to optimize patient engagement and clinical operations using data, automation, and trusted AI. This offering empowers pharmaceutical and medical technology organizations to streamline patient engagement, clinical operations, commercial lifecycle management, and personalized stakeholder experiences across the entire drug and device development journey.

Which Key Market Players Are Investing In Expansion And Innovation Of Pharma And Biotech CRM Software Market?

Major companies operating in the pharma and biotech CRM software market are Oracle Corporation, Salesforce.com Inc., IQVIA Holdings Inc., Trueblue Inc., Cirrius Solutions Inc., Veeva Systems Inc., Aurea Software Inc., Indegene Private Limited, Close-Up International Limited, Interactive Medica S.A., StayinFront Inc., Axtria Inc., Navicon Consulting LLC, Aktana Inc., Bpmonline, AKA Enterprise Solutions LLC, Anthill Agency Ltd., Media-Soft Inc., Zephyr Health Inc., Synergistix Inc., Euris S.A., Inova Software Inc., Prolifiq Software Inc., Infonis International Corp., Ivy Software Development Services Pvt. Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/pharma-and-biotech-crm-software-global-market-report

What Are The Key Regional Factors Influencing The Pharma And Biotech CRM Software Market Growth?

North America was the largest region in the pharma and biotech CRM software market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharma and biotech crm software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Pharma And Biotech CRM Software Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15442&type=smp

Browse Through More Reports Similar to the Global Pharma And Biotech CRM Software Market 2025, By The Business Research Company

Pharmaceutical Chemicals Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pharmaceutical-chemicals-global-market-report

Biopharmaceutical Cmo Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biopharmaceutical-cmo-global-market-report

E Pharmacy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/e-pharmacy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795